Importantly, we found that E2f1 and E2f3 consistently bound with higher affinity to cell cycle target genes compared with metabolic target genes at any time of TKO HCC progression (Fig. 7a,b; see Fig. 2b for the list of the 11 target genes). The gene discussed is E2F3; the disease is hepatocellular carcinoma.